Medizinischer Rat für internationale Kommunikation (IOMC) |

GET THE APP

Extrait/Indexé dans

Ouvrez la porte J, Génamique, Google Scholar, ISA (résumés scientifiques indiens), Base de données CAS (Chemical Abstract Services), CABI (Royaume-Uni), Index Copernic, Hinar, EBSCO, Répertoire des périodiques d'Ulrich, Pesticides botaniques , Résumés de mauvaises herbes, AgBiotechNet, Ressource VetMed, Résumés de physiologie des cultures, Abrégés d'agroforesterie, Résumés helminthologiques, Horticulture ornementale, Abrégés de phytogénétiques, Novelles and informations on the porc, Abrégés sur les sciences laitières, Basis der Données sur Landwirtschaftliche Wirtschaft, Basis für Parasitologie-Studien, CAB-Lebensläufe, Zoologisches Register, Neue und nachträgliche Informationen, Basis für Ernährungs- und Lebensmittelwissenschaften, Basis für biologische Forschung, Weltgesundheit, ABC Chimie, Zentrum des Wissenschaften,SCIMAGO ist ein Zug,der viele andere Charaktere verrät.

Avis

Reducing The Risk of Pancreatic Cancer Using Microbiome

Francesco Nicoldi

In the coming decades, there will likely be an increase in pancreatic cancer mortality. A poor prognosis for this aggressive cancer is caused by late detection and therapy resis..Voir plus»

Mini examen

Cranial Nerve Involvement in Neuralgic Amyotrophy

Pietro E Doneddu, Elia Sechi, Alberto Addis, Giulia Fadda, Chiara Fois and GianPietro Sechi

Neuralgic Amyotrophy (NA) is generally conceived as a multifocal neuropathy of the brachial plexus. However, different atypical forms with the involvement of ot..Voir plus»

Éditoriaux

International Conference on Smart Computing and Communication (SmartTech-2017)

Deepshikha Bhargava, Ramesh C. Poonia, Swapnesh Taterh

"With the development of high throughput sequencing technology, massive amount of genomic data are generated every day. To efficiently handle these data for storage, proces..Voir plus»

Article de perspective

Variable Market Exclusivity Periods for Pharmaceuticals

Michael Hsu, Ali Thaver and Gerard Anderson*

Pharmaceutical companies are given a market exclusivity period that does not vary based on the level of research and development (R&D) or the profits earned. The main purpos..Voir plus»